Literature DB >> 33478604

Catastrophic cognitions about coronavirus: the Oxford psychological investigation of coronavirus questionnaire [TOPIC-Q].

Laina Rosebrock1,2, Emma Černis1,2, Sinéad Lambe1,2, Felicity Waite1,2, Stephanie Rek3,4, Ariane Petit1,2, Anke Ehlers2,5, David M Clark2,5, Daniel Freeman1,2.   

Abstract

BACKGROUND: Cognitive therapies are developed on the principle that specific cognitive appraisals are key determinants in the development and maintenance of mental health disorders. It is likely that particular appraisals of the coronavirus pandemic will have explanatory power for subsequent mental health outcomes in the general public. To enable testing of this hypothesis we developed a questionnaire assessing coronavirus-related cognitions.
METHODS: 12 285 participants completed online a 46-item pool of cognitions about coronavirus and six measures of different mental health problems. The sample was randomly split into derivation and validation samples. Exploratory factor analyses determined the factor structure, selection of items, and model fit in the derivation sample. Confirmatory factor analysis (CFA) then tested this model in the validation sample. Associations of the questionnaire with mental health outcomes were examined.
RESULTS: The 26-item, seven-factor, Oxford Psychological Investigation of Coronavirus Questionnaire [TOPIC-Q] was developed. CFA demonstrated a good model fit (χ2 = 2108.43, df = 278, p < 0.001, comparative fit index (CFI) = 0.950, Tucker-Lewis index (TLI) = 0.942, root mean square error of approximation (RMSEA) = 0.033, standardized root mean square residual (SRMR) = 0.038). The factors were: cognitions about (1) safety and vulnerability, (2) negative long-term impact, (3) having the virus, (4) spreading the virus, (5) social judgment, (6) negative self, and (7) being targeted. The questionnaire explained significant variance in depression (45.8%), social anxiety (37.3%), agoraphobia (23.2%), paranoia (27.3%), post-traumatic stress disorder (57.1%), and panic disorder (31.4%). Cognitions about negative long-term impact had the greatest explanatory power across disorders.
CONCLUSIONS: TOPIC-Q provides a method to assess appraisals of the pandemic, which is likely to prove helpful both in longitudinal studies assessing mental health outcomes and in delivery of psychological therapy.

Entities:  

Keywords:  COVID-19; cognitions; cognitive therapy; coronavirus; factor analysis; mental health; stress

Year:  2021        PMID: 33478604      PMCID: PMC7884724          DOI: 10.1017/S0033291721000283

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  16 in total

1.  Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale.

Authors:  K M Connor; J R Davidson; L E Churchill; A Sherwood; E Foa; R H Weisler
Journal:  Br J Psychiatry       Date:  2000-04       Impact factor: 9.319

2.  A cognitive approach to panic.

Authors:  D M Clark
Journal:  Behav Res Ther       Date:  1986

3.  The Mobility Inventory for Agoraphobia.

Authors:  D L Chambless; G C Caputo; S E Jasin; E J Gracely; C Williams
Journal:  Behav Res Ther       Date:  1985

4.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

5.  Multicenter collaborative panic disorder severity scale.

Authors:  M K Shear; T A Brown; D H Barlow; R Money; D E Sholomskas; S W Woods; J M Gorman; L A Papp
Journal:  Am J Psychiatry       Date:  1997-11       Impact factor: 18.112

6.  Does old age reduce the risk of anxiety and depression? A review of epidemiological studies across the adult life span.

Authors:  A F Jorm
Journal:  Psychol Med       Date:  2000-01       Impact factor: 7.723

Review 7.  A cognitive model of posttraumatic stress disorder.

Authors:  A Ehlers; D M Clark
Journal:  Behav Res Ther       Date:  2000-04

8.  The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses.

Authors:  Stefan G Hofmann; Anu Asnaani; Imke J J Vonk; Alice T Sawyer; Angela Fang
Journal:  Cognit Ther Res       Date:  2012-07-31

9.  The depressive state of Denmark during the COVID-19 pandemic.

Authors:  Kim Mannemar Sønderskov; Peter Thisted Dinesen; Ziggi Ivan Santini; Søren Dinesen Østergaard
Journal:  Acta Neuropsychiatr       Date:  2020-04-22       Impact factor: 3.403

10.  COVID-19 pandemic and mental health consequences: Systematic review of the current evidence.

Authors:  Nina Vindegaard; Michael Eriksen Benros
Journal:  Brain Behav Immun       Date:  2020-05-30       Impact factor: 7.217

View more
  5 in total

1.  Increased Risk Perception, Distress Intolerance and Health Anxiety in Stricter Lockdowns: Self-Control as a Key Protective Factor in Early Response to the COVID-19 Pandemic.

Authors:  Christoph Lindner; Ibolya Kotta; Eszter Eniko Marschalko; Kinga Szabo; Kinga Kalcza-Janosi; Jan Retelsdorf
Journal:  Int J Environ Res Public Health       Date:  2022-04-22       Impact factor: 4.614

2.  Information seeking and health anxiety during the COVID-19 pandemic: The mediating role of catastrophic cognitions.

Authors:  Shreya Jagtap; Amanda L Shamblaw; Rachel Rumas; Michael W Best
Journal:  Clin Psychol Psychother       Date:  2021-11-13

3.  The Impact of COVID-19 on Behavior and Physical and Mental Health of Romanian College Students.

Authors:  Sînziana Călina Silișteanu; Maria Totan; Oana Raluca Antonescu; Lavinia Duică; Elisabeta Antonescu; Andrei Emanuel Silișteanu
Journal:  Medicina (Kaunas)       Date:  2022-02-06       Impact factor: 2.430

4.  Pandemic paranoia in the general population: international prevalence and sociodemographic profile.

Authors:  Lyn Ellett; Björn Schlier; Jessica L Kingston; Chen Zhu; Suzanne Ho-Wai So; Tania M Lincoln; Eric M J Morris; Brandon A Gaudiano
Journal:  Psychol Med       Date:  2022-09-06       Impact factor: 10.592

5.  The Pandemic Paranoia Scale (PPS): factor structure and measurement invariance across languages.

Authors:  J L Kingston; B Schlier; L Ellett; S H So; B A Gaudiano; E M J Morris; T M Lincoln
Journal:  Psychol Med       Date:  2021-12-09       Impact factor: 7.723

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.